Lymphedema attributed to sirolimus

Lymphedema attributed to sirolimus

Bibliographic Details
Main Author:	Ardalan Mohammad-Reza
Format:	Article
Language:	English
Published:	Society of Diabetic Nephropathy Prevention 2013-04-01
Series:	Journal of Nephropharmacology
Subjects:	Immunosuppression Sirolimus Transplantation
Online Access:	http://www.jnephropharmacology.com/PDF/NPJ-2-35.pdf

Similar Items

Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression
by: Szilvia Bak, et al.
Published: (2018-12-01)

Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patients
by: Herlinda Reyes-Pérez, et al.
Published: (2016-01-01)

Favorable Results of Concomitant Tacrolimus and Sirolimus Therapy in Taiwanese Renal Transplant Recipients at 12 Months
by: Kuo-Hsin Chen, et al.
Published: (2008-07-01)

Reversible sirolimus-induced pulmonary alveolar proteinosis in a renal transplant patient
by: David Eugenio Hinojosa-González, et al.
Published: (2020-01-01)

Efficacy and safety of early tacrolimus conversion to sirolimus after kidney transplantation: Long-term results of a prospective randomized study
by: A E El-Agroudy, et al.
Published: (2017-01-01)

Safety and effectiveness of everolimus compared with sirolimus and tacrolimus in preventing kidney transplantation rejection: a systematic review and meta-analysis
by: Morteza Arab Zozani, et al.
Published: (2015-08-01)

Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects
by: Simona Granata, et al.
Published: (2016-05-01)

Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea
by: Hee Jung Jeon, et al.
Published: (2018-08-01)

Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial
by: Kwang-Woong Lee, et al.
Published: (2020-10-01)

De novo cancer avoidance after renal transplantation: A case–control study on low-dose sirolimus combined with a calcineurin inhibitor
by: Kuo-Hsin Chen, et al.
Published: (2015-06-01)

Pancreatic Kaposiform Hemangioendothelioma Not Responding to Sirolimus
by: Paloma Junco Triana, et al.
Published: (2017-01-01)

Outcomes of treatment with sirolimus for non-infectious uveitis: a meta-analysis and systematic review
by: Cabahug VLO, et al.
Published: (2019-04-01)

Effect of oral sirolimus therapy on inflammatory biomarkers following coronary stenting
by: W.C.M. Rosa, et al.
Published: (2010-08-01)

Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation
by: G.A. Spinelli, et al.
Published: (2006-01-01)

Effects of sirolimus on Lung function in patients with Lymphangioleiomyomatosis
by: Fatemeh Aghaeimeybodi, et al.
Published: (2019-01-01)

The Effects of Lyophilization on the Physico-Chemical Stability of Sirolimus Liposomes
by: Parvin Zakeri-Milani, et al.
Published: (2013-02-01)

Low-dose sirolimus in retroperitoneal lymphangioleiomyomas
by: Kamonpun Ussavarungsi, et al.
Published: (2019-01-01)

Pulmonary lymphangioleiomyomatosis presenting as spontaneous pneumothorax treated with sirolimus - A case report
by: Ajay Kumar Verma, et al.
Published: (2018-01-01)

Sirolimus may be associated with early recurrence of biliary obstruction in liver transplant patients undergoing endoscopic stenting of biliary strictures
by: James H. Tabibian, MD., et al.
Published: (2011-07-01)

Topical sirolimus in facial angiofibroma
by: Prachi Chetankumar Gajjar, et al.
Published: (2018-01-01)

De novo Renal Transplantation after Kaposi Sarcoma: Favorable Outcome in a Patient Receiving Sirolimus and Mycophenolate-Based Immunosuppression
by: F. Friedersdorff, et al.
Published: (2010-04-01)

Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis
by: Siqi Hu, et al.
Published: (2019-08-01)

Reduction of left ventricular hypertrophy by Sirolimus in kidney transplant recipients: a nonrandomized clinical trial
by: Sedghipour M, et al.
Published: (2012-02-01)

Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio Impact of stenting and oral sirolimus on endothelium-dependent and independent coronary vasomotion
by: Rósley Weber Alvarenga Fernandes, et al.
Published: (2012-04-01)

Gorham-Stout Disease with Clinical Response to Sirolimus Treatment
by: Santiago Forero Saldarriaga, et al.
Published: (2021-08-01)

Exploring sirolimus pharmacokinetic variability using data available from the routine clinical care of renal transplant patients: Population pharmacokinetic approach
by: Golubović Bojana, et al.
Published: (2019-01-01)

Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus
by: Ahmed M. Alkhunaizi, et al.
Published: (2020-01-01)

Facial angiofibromas of tuberous sclerosis treated with topical sirolimus in an Indian patient
by: Resham J Vasani
Published: (2015-01-01)

In vivo and in vitro toxicity evaluation of liposome-encapsulated sirolimus
by: Murilo Batista Abud, et al.
Published: (2019-09-01)

Use of Oral Sirolimus in Paediatric Patients with Serious Vascular Anomalies: Case Report
by: Maria Jesus Garcia Verde, et al.
Published: (2018-01-01)

Sirolimus for Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon in a Neonate
by: Trevor B. Cabrera, et al.
Published: (2020-10-01)

Efficacy and Tolerance of Sirolimus (Rapamycin) for Extracranial Arteriovenous Malformations in Children and Adults
by: Romain Gabeff, et al.
Published: (2019-09-01)

Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review
by: Shira Sandbank, et al.
Published: (2019-08-01)

Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats
by: Mehmet Necmettin Mercimek, et al.
Published: (2019-09-01)

Conversion from calcineurin inhibitors to sirolimus of recipients with chronic kidney graft disease grade iii for a period 2003-2011
by: Ignjatović Ljiljana, et al.
Published: (2013-01-01)

The role of sirolimus in proteinuria in diabetic nephropathy rats
by: JinJun Wang, et al.
Published: (2017-12-01)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
by: Kirby Sean, et al.
Published: (2012-03-01)

Eficácia e segurança do Sirolimus associado a tacrolimus em baixas doses em paciente idoso transplantado renal
by: Kojima, Christiane Akemi [UNESP]
Published: (2016)

Efficacy of sirolimus for the prevention of recurrent pneumothorax in patients with lymphangioleiomyomatosis: a case series
by: Li Zhou, et al.
Published: (2018-09-01)

Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study
by: Yongzhong Zhan, et al.
Published: (2018-02-01)